Neurology

In this article, Ana Suller-Marti, Associate Professor of Neurology, Western University, London, Canada; James Wheless, Professor and…

Inside this issue, you will find a variety of content, including our independent review of the 11th Congress of the EAN, alongside exclusive..

Interview article with Prof. Abdelmoity, discussing the current treatment landscape for patients with drug-resistant epilepsy (DRE)…

CAR T Therapy: The NEX-T Frontier in MS, a BMS non-promotional symposium at ECTRIMS 2024, presents a thought-provoking view on the potential role of CAR-T cell therapy in Multiple Sclerosis. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. (IMM-GB-2400302) | Date of Prep: June 2025

This interview with a top thought leader from McGill University in Canada educates clinicians on important innovations in the field…

Learn about Becker Muscular Dystrophy (Becker), a serious, rare, and debilitating neuromuscular disease…

This article describes a recently initiated Phase II trial of a novel anti-tau monoclonal antibody, BMS-986446, the design for which was…

A satellite symposium titled ‘Transforming MS Care: Early Intervention and Sustained Safety’ held at the 40th Congress of the European…

Great advances have been made in the field of generalised myasthenia gravis (gMG) in recent years; however, many patients remain…

This article summarises a fascinating interview with neurologist Antonietta Coppola, University of Naples Federico II, Italy, in which she…

A feature calling for a biological definition for Parkinson’s disease, and an article highlighting the importance of early recognition…

A masterclass initiated, organised, and funded by UCB, sought to advance understanding and expertise of myelin oligodendrocyte…

Non-seizure symptoms in Dravet and Lennox-Gastaut syndromes can affect speech, gait, appetite, mood, development, and sleep and impact…

There is a lot of excitement in the field of amyotrophic lateral sclerosis. Scientific progress has resulted in an ever-growing pipeline…

Lennox–Gastaut syndrome (LGS), a severe childhood-onset epilepsy syndrome, can be challenging to identify due to its heterogeneous…

Our latest issue of EMJ Neurology features a captivating array of peer-reviewed articles, exclusive interviews with renowned experts, and…

While people with multiple sclerosis (MS) are not more likely to contract COVID-19, the incidences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19-related complications may be higher for people with MS who have comorbidities or who are taking certain disease modifying therapies (DMT).

Welcome to the EMJ review of the 38th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2022 Congress, which took place in Amsterdam, the Netherlands, on 26th–28th October. This review showcases key abstract presentations, including an analysis on the value of serum neurofilament light chain in predicting multiple sclerosis diagnosis and future disability.

Welcome to our latest issue of EMJ Neurology, our updates on the latest research and expert insights in the field. Just some of the featured articles include a review of adiposity and neurological disorders, an analysis of sex-related differences in stroke presentation, and a rare case of paediatric NMDAR encephalitis.

This infographic explores depression in patients with epilepsy, focusing on the impact of the COVID-19 pandemic. Questioning what healthcare professionals can do to help, this infographic analyses the epidemiology of depression and notes the differences between patients with controlled epilepsy and those with drug-resistant epilepsy.

This symposium review of presentations made at the World Muscle Society (WMS) 2021 Virtual Congress draws a spotlight upon two monogenic neuromuscular diseases: spinal muscular atrophy (SMA) and Duchenne muscular dystrophy. 

‘Emerging Treatment Strategies for Motor Fluctuation Management: Therapeutic Options for Newly Detected Motor Fluctuations’ reviews…

In this supplement text to EMJ Neurology, two key opinion leaders, Mark S Freedman and Lluís Ramió-Torrentà, discussed the current approaches and challenges in the assessment of disease activity and progression in relapsing-remitting multiple sclerosis (RRMS). The interviewees also provide their perspectives on this topic of disease activity and progression in patients with RRMS, including an overview of the measurement tools that can be utilised in clinical practice.

The global burden of Alzheimer’s disease is increasing exponentially, affecting both the developed and developing world. Valuable…